Australia markets closed

DexCom, Inc. (DXCM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
117.47-5.19 (-4.23%)
As of 02:40PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close122.67
Open121.65
Bid117.22 x 1100
Ask117.23 x 900
Day's range116.01 - 122.33
52-week range66.89 - 144.96
Volume2,028,253
Avg. volume2,839,055
Market cap45.376B
Beta (5Y monthly)1.13
PE ratio (TTM)261.06
EPS (TTM)0.45
Earnings date08 Feb 2023 - 13 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est125.24
  • Motley Fool

    Have $1,000? 2 Smart Stocks to Buy in a Nasdaq Bear Market

    With the Nasdaq Composite still firmly entrenched in bear market territory, if you're feeling discouraged about the state of your portfolio and the performance of some of your favorite stocks, you're certainly not alone. Two stocks that in my view belong firmly in the former category are DexCom (NASDAQ: DXCM) and Procter & Gamble (NYSE: PG). If you're searching for a non-cyclical company with products that are consistently in demand, regardless of the macro environment or consumer sentiment, DexCom could be a no-brainer contender for your portfolio.

  • Business Wire

    Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.

    SAN DIEGO, December 08, 2022--Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.

  • Motley Fool

    2 Monster Stocks to Buy Without Any Hesitation

    With that, let's take a look at two top growth stocks to consider adding to your portfolio before the year is out. On the contrary, Etsy stands to benefit considerably from the consumer-driven tailwinds driving prolonged growth in the global e-commerce market, a space on track to hit a valuation of roughly $63 trillion by the year 2030.